NCT02848872View on ClinicalTrials.gov

Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer

CompletedOBSERVATIONAL

Enrollment

25

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

April 2, 2019

Study Completion Date

April 2, 2019

Conditions

Non-small Cell Lung Carcinoma

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT02848872 - Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter